Search research articles
Contact Us
Filters
Showing results (581-590 of 735) with videos related to
Page
of 74
Sort By:
Cellular Immunology
|
February 1, 1996
Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated function
H Cui, D H Sherr, M el-Khatib, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 6, 2001
Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis
A M Taveira-DaSilva, C Hedin, M P Stylianou, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Combined oral administration of etoposide and arabinofuranosylcytosine-5'-stearylphosphate enhances the antitumor effect against P388 ascites tumors
M Higashigawa, D C Cao, K Matsui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 1, 1987
[Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer]
M Fukuoka, M Takada, T Kamei, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
November 1, 1989
[PTCA and coronary artery bypass operation prior to subsequent surgery of gastric cancer in patients with coronary artery disease]
H Kohno, A Nakashima, K Matsui, et al.
Acta Endocrinologica
|
October 1, 1987
The effect of short-lasting atrial pacing on the release of atrial natriuretic peptide, vasopressin, and methionine enkephalin in man
K Ota, T Kimura, M Ito, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 1988
Both B151-T cell replacing factor 1 and IL-5 regulate Ig secretion and IL-2 receptor expression on a cloned B lymphoma line
K Nakanishi, T Yoshimoto, Y Katoh, et al.
International Immunology
|
May 1, 1996
IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation
K Nakanishi, K Matsui, S Kashiwamura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 1, 1991
[High-dose Tegafur (FT) for primary lung cancer: a phase I trial]
K Matsui, M Fukuoka, N Masuda, et al.
American Journal of Clinical Oncology
|
February 1, 1992
Weekly dose-intensive chemotherapy in patients with small-cell lung cancer: a pilot study
S Kudoh, M Fukuoka, S Negoro, et al.
Page
of 74
Search research articles
Search
Showing results (581-590 of 735) with videos related to
Sort By:
Page
of 74
Cellular Immunology
|
February 1, 1996
Regulation of T-cell death genes: selective inhibition of FasL- but not Fas-mediated function
H Cui, D H Sherr, M el-Khatib, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 6, 2001
Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis
A M Taveira-DaSilva, C Hedin, M P Stylianou, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1994
Combined oral administration of etoposide and arabinofuranosylcytosine-5'-stearylphosphate enhances the antitumor effect against P388 ascites tumors
M Higashigawa, D C Cao, K Matsui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 1, 1987
[Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer]
M Fukuoka, M Takada, T Kamei, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
November 1, 1989
[PTCA and coronary artery bypass operation prior to subsequent surgery of gastric cancer in patients with coronary artery disease]
H Kohno, A Nakashima, K Matsui, et al.
Acta Endocrinologica
|
October 1, 1987
The effect of short-lasting atrial pacing on the release of atrial natriuretic peptide, vasopressin, and methionine enkephalin in man
K Ota, T Kimura, M Ito, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 1988
Both B151-T cell replacing factor 1 and IL-5 regulate Ig secretion and IL-2 receptor expression on a cloned B lymphoma line
K Nakanishi, T Yoshimoto, Y Katoh, et al.
International Immunology
|
May 1, 1996
IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation
K Nakanishi, K Matsui, S Kashiwamura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
April 1, 1991
[High-dose Tegafur (FT) for primary lung cancer: a phase I trial]
K Matsui, M Fukuoka, N Masuda, et al.
American Journal of Clinical Oncology
|
February 1, 1992
Weekly dose-intensive chemotherapy in patients with small-cell lung cancer: a pilot study
S Kudoh, M Fukuoka, S Negoro, et al.
Page
of 74